The Kanagawa Children's Medical Center is a children's hospital in Yokohama, Japan. The center is a core facility of pediatric care for Kanagawa Prefecture. It consists of a research institute and hospital, and is now an ancillary establishment of Kanagawa Prefectural Hospital Organization.

There are 419 beds in Kanagawa Children's Medical Center.

During the past decade, Kanagawa Children's Medical Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kanagawa Children's Medical Center" #1 sponsor was "Pfizer" with 4 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Takeda" with 3 trials sponsored, "Bayer" with 1 trials sponsored and "Children's Oncology Group" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kanagawa Children's Medical Center" #1 collaborator was "Kyowa Kirin Co., Ltd." with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Kanagawa Children's Medical Center" are "Dravet Syndrome (DS)" (2 trials), "Juvenile Idiopathic Arthritis" (2 trials), "Urinary Bladder, Neurogenic" (2 trials), "Aspergillosis, Aspergilloma" (1 trials) and "Childhood Extracranial Germ Cell Tumor" (1 trials). Many other conditions were trialed in "Kanagawa Children's Medical Center" in a lesser frequency.

Most popular intervention types in "Kanagawa Children's Medical Center" are "Drug" (16 trials), "Biological" (3 trials), "Other" (2 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (3 trials), "Placebo" (3 trials), "Fesoterodine BIC 2 mg" (2 trials), "Fesoterodine BIC 4 mg" (2 trials) and "Fesoterodine PR 4 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kanagawa Children's Medical Center" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Kanagawa Children's Medical Center". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Kanagawa Children's Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kanagawa Children's Medical Center, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".